Lyell Immunopharma Inc (LYEL) support and resistance · rev $6.0K
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
This page maps Lyell Immunopharma Inc (LYEL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
LYEL currently screens at market cap $143.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LYEL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LYEL quote page for the session range and the stock page for the full model.
Not investment advice.